Qingwen Wang

869 total citations
28 papers, 622 citations indexed

About

Qingwen Wang is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Qingwen Wang has authored 28 papers receiving a total of 622 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Nephrology, 10 papers in Pulmonary and Respiratory Medicine and 7 papers in Oncology. Recurrent topics in Qingwen Wang's work include Renal Diseases and Glomerulopathies (9 papers), Chronic Kidney Disease and Diabetes (4 papers) and Ferroptosis and cancer prognosis (3 papers). Qingwen Wang is often cited by papers focused on Renal Diseases and Glomerulopathies (9 papers), Chronic Kidney Disease and Diabetes (4 papers) and Ferroptosis and cancer prognosis (3 papers). Qingwen Wang collaborates with scholars based in China, Finland and United States. Qingwen Wang's co-authors include Zhihong Liu, LI Leishi, Shijun Li, Huimei Chen, Caihong Zeng, Huiping Chen, Bihua Xu, Hui Y. Lan, Yong‐Ke You and Jingyi Sheng and has published in prestigious journals such as Journal of Medicinal Chemistry, American Journal of Kidney Diseases and Metabolism.

In The Last Decade

Qingwen Wang

27 papers receiving 611 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qingwen Wang China 13 363 125 113 89 85 28 622
Kevin S. Eardley United Kingdom 7 259 0.7× 176 1.4× 107 0.9× 49 0.6× 123 1.4× 8 665
Katsuyuki Nagatoya Japan 11 262 0.7× 207 1.7× 140 1.2× 38 0.4× 101 1.2× 29 603
Mitsumasa Nagase Japan 14 320 0.9× 108 0.9× 85 0.8× 36 0.4× 68 0.8× 50 634
Motokazu Matsuura Japan 13 190 0.5× 195 1.6× 81 0.7× 72 0.8× 59 0.7× 30 538
R. Riess Germany 12 233 0.6× 203 1.6× 153 1.4× 61 0.7× 114 1.3× 22 705
Virginie Huart France 8 187 0.5× 107 0.9× 136 1.2× 26 0.3× 79 0.9× 9 493
Tomohiro Kaneko Japan 16 299 0.8× 202 1.6× 120 1.1× 25 0.3× 74 0.9× 61 853
Claudia Fofi Italy 9 209 0.6× 98 0.8× 60 0.5× 34 0.4× 61 0.7× 21 447
Ken Iseri Japan 15 327 0.9× 104 0.8× 88 0.8× 48 0.5× 63 0.7× 38 576
Shintaro Mandai Japan 17 243 0.7× 278 2.2× 162 1.4× 38 0.4× 107 1.3× 60 681

Countries citing papers authored by Qingwen Wang

Since Specialization
Citations

This map shows the geographic impact of Qingwen Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingwen Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingwen Wang more than expected).

Fields of papers citing papers by Qingwen Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qingwen Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingwen Wang. The network helps show where Qingwen Wang may publish in the future.

Co-authorship network of co-authors of Qingwen Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Qingwen Wang. A scholar is included among the top collaborators of Qingwen Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingwen Wang. Qingwen Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Qingwen, et al.. (2023). Discovery of Pyrazolone Carbothioamide Derivatives as Inhibitors of the Pdr1-KIX Interaction for Combinational Treatment of Azole-Resistant Candidiasis. Journal of Medicinal Chemistry. 66(17). 11893–11904. 6 indexed citations
2.
3.
Cong, Lin, et al.. (2023). A Comparative Study of Antitumor Immunity Induced by Radiofrequency Microwave and Cryoablation in Hepatocellular Carcinoma. Applied Biochemistry and Biotechnology. 196(7). 4088–4104. 3 indexed citations
4.
Zhang, Shuya, et al.. (2023). Testicular ischemia associated with IgA vasculitis in a child: a case report and literature review. Frontiers in Pediatrics. 11. 1219878–1219878. 1 indexed citations
5.
Wang, Yujin, Qingwen Wang, Donghu Yu, et al.. (2021). Osteopontin improves sensitivity to tyrosine kinase inhibitor in lung adenocarcinoma in vitro by promoting epidermal growth factor receptor phosphorylation. Journal of Cancer Research and Clinical Oncology. 147(11). 3245–3254. 2 indexed citations
6.
Guo, Zixin, Xin Yan, Congkuan Song, et al.. (2021). FAT3 Mutation Is Associated With Tumor Mutation Burden and Poor Prognosis in Esophageal Cancer. Frontiers in Oncology. 11. 603660–603660. 21 indexed citations
7.
Song, Congkuan, Zhi-Quan Wu, Qingwen Wang, et al.. (2021). A Combined Two-mRNA Signature Associated With PD-L1 and Tumor Mutational Burden for Prognosis of Lung Adenocarcinoma. Frontiers in Cell and Developmental Biology. 9. 634697–634697. 12 indexed citations
8.
Song, Congkuan, Zixin Guo, Xiaoyan Shen, et al.. (2020). Prognostic Factors Analysis and Nomogram Construction of Dual Primary Lung Cancer: A Population Study. BioMed Research International. 2020(1). 7206591–7206591. 7 indexed citations
9.
Song, Congkuan, Donghu Yu, Yujin Wang, et al.. (2020). Dual Primary Cancer Patients With Lung Cancer as a Second Primary Malignancy: A Population-Based Study. Frontiers in Oncology. 10. 515606–515606. 15 indexed citations
10.
Liu, Ming, et al.. (2020). A novel three-dimensional template combined with MR-guided 125I brachytherapy for recurrent glioblastoma. Radiation Oncology. 15(1). 146–146. 16 indexed citations
11.
Xu, Bihua, Jingyi Sheng, Yong‐Ke You, et al.. (2019). Deletion of Smad3 prevents renal fibrosis and inflammation in type 2 diabetic nephropathy. Metabolism. 103. 154013–154013. 98 indexed citations
12.
Dong, Jing, et al.. (2017). [Targeted degradation of epidermal growth factor receptor in nasopharyngeal carcinoma by chimeric molecule].. PubMed. 31(4). 297–300. 1 indexed citations
13.
14.
Chen, Hui‐Mei, Yan Chen, Yide Zhang, et al.. (2010). Evaluation of Metabolic Risk Marker in Obesity-related Glomerulopathy. Journal of Renal Nutrition. 21(4). 309–315. 11 indexed citations
15.
Chen, Huimei, Shijun Li, Huiping Chen, et al.. (2008). Obesity-Related Glomerulopathy in China: A Case Series of 90 Patients. American Journal of Kidney Diseases. 52(1). 58–65. 78 indexed citations
16.
Chen, Yu, Zheng Tang, Qingwen Wang, et al.. (2007). Long-Term Efficacy of Tonsillectomy in Chinese Patients with IgA Nephropathy. American Journal of Nephrology. 27(2). 170–175. 40 indexed citations
17.
Deau, Jacques T. Ya, et al.. (2005). Hemodynamic Effects of Di-Sec-Butyl Phenol, an Anesthetic Substituted Phenol. Pharmacology. 76(3). 117–122. 1 indexed citations
18.
Tang, Zheng, Yan Wu, Qingwen Wang, et al.. (2003). Clinical spectrum of diffuse crescentic glomerulonephritis in Chinese patients.. PubMed. 116(11). 1737–40. 19 indexed citations
19.
Zeng, Qingyu, et al.. (2003). Primary gout in Shantou: a clinical and epidemiological study.. PubMed. 116(1). 66–9. 29 indexed citations
20.
Tang, Zheng, Qingwen Wang, Yu‐Sheng Yu, et al.. (2002). Idiopathic IgA Nephropathy with Diffuse Crescent Formation. American Journal of Nephrology. 22(5-6). 480–486. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kevin S. Eardley Breakdown of academic impact, for papers by Katsuyuki Nagatoya Breakdown of academic impact, for papers by Mitsumasa Nagase Breakdown of academic impact, for papers by Motokazu Matsuura Breakdown of academic impact, for papers by R. Riess Breakdown of academic impact, for papers by Virginie Huart Breakdown of academic impact, for papers by Tomohiro Kaneko Breakdown of academic impact, for papers by Claudia Fofi Breakdown of academic impact, for papers by Ken Iseri Breakdown of academic impact, for papers by Shintaro Mandai
Rankless by CCL
2026